. Correction to: Multicenter Real-World Study on Effectiveness and Early Discontinuation Predictors in Patients With Non-small Cell Lung Cancer Receiving Nivolumab. Oncologist 2022 Aug 6. pii: 6657714. doi: 10.1093.
PMID: 35932280